Merck is expanding domestic manufacturing with a $895 million investment in its Kansas factory, one of several major projects ...

The drugmaker Merck announced it has opened a $1 billion vaccine manufacturing facility in north Durham, a 225,000-square-foot addition to the company’s existing campus off Old Oxford Road.

Drugmaker Merck announced Tuesday the opening of a new facility in North Durham. The $1 billion plant will manufacture the HPV vaccines Gardasil and Gardasil 9, while the site continues to produce ...

The 470,000-square-foot facility will support the launch and commercial production of next-generation biologics and therapies ...

MSD has begun construction on a $1bn biologics centre of excellence, Merck Wilmington Biotech, in the US state of Delaware.

After developing treatments for rare tumors, SpringWorks Therapeutics is taking a buyout offer from Germany-based Merck KGaA.

In March, Merck opened a new $1 billion, 225,000-square-foot vaccine manufacturing facility at its site in Durham, North Carolina. The expansion is a crucial component of the more than $12 ...

Biopharmaceutical giant Merck (NYSE: MRK) has broken ground on a $1 billion pharmaceutical manufacturing facility in ...

Merck starts construction on a $1B biologics facility in Wilmington, Del., expected to create 500+ jobs and support Keytruda production.

Emily Barefoot, associate specialist, engineering, at Merck & Co. in Durham, began her role in the process support lab in July 2022. Her work supports all of the manufacturing sites at Merck ...

Located at Chestnut Run Innovation & Science Park, the Merck Wilmington Biotech project will comprise laboratory, ...